Vaginal misoprostol may leads to higher pain relief compared with surgical evacuation of uterus (low certainty).
Vaginal misoprostol showed no clear difference in woman’s satisfaction/acceptability of method compared with surgical evacuation of uterus (low certainty).
The review found no eligible studies for this question.
Vaginal misoprostol showed no clear difference in nausea compared with placebo (low certainty).
Vaginal misoprostol showed no clear difference in diarrhoea compared with placebo (low certainty).
It is very uncertain whether vaginal misoprostol changes blood loss: haemoglobin difference > 10 g/L compared with placebo (very low certainty).
It is very uncertain whether vaginal misoprostol changes pain (opiate use) compared with placebo (very low certainty).
Vaginal misoprostol showed no clear difference in woman’s satisfaction/acceptability of method compared with placebo (low certainty).
Vaginal misoprostol may leads to lower complete miscarriage compared with surgical evacuation of uterus (low certainty).
Vaginal misoprostol showed no clear difference in pelvic infection compared with surgical evacuation of uterus (low certainty).
The intervention showed no clear difference in risk of adverse events (until time of hospital discharge) (moderate certainty).
It is very uncertain whether shock wave lithotripsy changes stone‐free rate compared with dissolution therapy (very low certainty).
It is very uncertain whether shock wave lithotripsy changes second procedures compared with ureteroscopy with holmium laser or pneumatic lithotripsy (very low certainty).
Shock wave lithotripsy probably leads to lower stone‐free rate compared with mini‐percutaneous nephrolithotripsy (moderate certainty).
Shock wave lithotripsy may leads to higher secondary procedures compared with mini‐percutaneous nephrolithotripsy (low certainty).